Legend: Palais des congrès de Montréal = CC, Le Westin Montréal = W, Intercontinental Montréal = I
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
A * preceding a session name means that the session is an applied session.
A ! preceding a session name means that the session reflects the JSM meeting theme.
Activity Details
|
|
Tweet | ||
| 32 * | Sun, 8/4/2013, 2:00 PM - 3:50 PM | CC-512h | |
| Analysis of Safety Data and Rare Events — Contributed Papers | |||
| Biopharmaceutical Section , Korean International Statistical Society | |||
| Chair(s): Mary Bartholomew, FDA Center for Veterinary Medicine | |||
| 2:05 PM | Statistical Methods Used in Safety Evaluation for NDA Submissions — Linyun Zhou, Takeda Global Research & Development | ||
| 2:20 PM | A Single-Arm Sequental Monitoring Design for Claiming Positive or Negative Safety Signals in Patients from Multiple Baseline Risk Groups — Jung Wook Park, Astellas Pharma Global Development, Inc. ; Xiaosha Sherman Zhang, Astellas Pharma Global Development, Inc. ; Jay Yang, Astellas Pharma Global Development Inc. ; Stephen Eck, Astellas Pharma Global Development, Inc. | ||
| 2:35 PM | A Second Source of Conservatism in Fisher's Exact Test for Rare Events — Mark Von Tress, Alcon Laboratories | ||
| 2:50 PM | Performance of Various Propensity Score Estimation Techniques for Estimating Relative Risks: A Simulation Study — Jiaxiao Shi, Kaiser Permanente ; Wansu Chen, Kaiser Permanente | ||
| 3:05 PM | Large-Scale Penalized Regression for Propensity Score Estimation in Observational Health Care Data — Ivan Zorych, Columbia University ; Patrick Ryan, Jenssen Research and Development LLC ; David Madigan, Columbia University | ||
| 3:20 PM | Signal Detections in Drug Safety Research — Li Zhu, Amgen ; Padmaja Chiruvolu, Amgen Inc ; Maggie Chen, Assent Consulting ; Liying Zhang, Assent Consulting ; Jinyu Yuan, Kforce ; Qi Jiang, Amgen | ||
| 3:35 PM | A Further Look Into Meta-Analysis of Rare Event Data for Drug Safety Assessment — Yujun Wu, Sanofi US ; Hui Quan, Sanofi ; Peng-liang Zhao, Sanofi US | ||
2013 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.
The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Copyright © American Statistical Association.